Crescera Capital Acquisition Corp (CREC) is a Blank Checks company listed on NASDAQ. There were no new wire items for CREC in the last 30 days. The most recent was published Feb 14, 2024.
Latest news
25 items- 13D/GSEC Form SC 13G filed by Crescera Capital Acquisition CorpSC 13G - Crescera Capital Acquisition Corp. (0001851230) (Subject)
- 13D/GSEC Form SC 13G/A filed by Crescera Capital Acquisition Corp (Amendment)SC 13G/A - Crescera Capital Acquisition Corp. (0001851230) (Subject)
- 13D/GSEC Form SC 13G/A filed by Crescera Capital Acquisition Corp (Amendment)SC 13G/A - Crescera Capital Acquisition Corp. (0001851230) (Subject)
- 13D/GSEC Form SC 13G/A filed by Crescera Capital Acquisition Corp (Amendment)SC 13G/A - Crescera Capital Acquisition Corp. (0001851230) (Subject)
- 13D/GSEC Form SC 13G/A filed by Crescera Capital Acquisition Corp (Amendment)SC 13G/A - Crescera Capital Acquisition Corp. (0001851230) (Subject)
- SECSEC Form 15-12G filed by Crescera Capital Acquisition Corp15-12G - Crescera Capital Acquisition Corp. (0001851230) (Filer)
- SECCrescera Capital Acquisition Corp filed SEC Form 8-K: Other Events, Financial Statements and Exhibits8-K - Crescera Capital Acquisition Corp. (0001851230) (Filer)
- SECSEC Form 10-Q filed by Crescera Capital Acquisition Corp10-Q - Crescera Capital Acquisition Corp. (0001851230) (Filer)
- SECSEC Form 10-Q filed by Crescera Capital Acquisition Corp10-Q - Crescera Capital Acquisition Corp. (0001851230) (Filer)
- SECSEC Form 25-NSE filed by Crescera Capital Acquisition Corp25-NSE - Crescera Capital Acquisition Corp. (0001851230) (Subject)
- SECCrescera Capital Acquisition Corp filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits8-K - Crescera Capital Acquisition Corp. (0001851230) (Filer)
- SECCrescera Capital Acquisition Corp filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits8-K - Crescera Capital Acquisition Corp. (0001851230) (Filer)
- NEWSGambling.com, Editas Medicine And Other Big Stocks Moving Lower In Thursday's Pre-Market SessionU.S. stock futures traded lower this morning. Here are some big stocks recording losses in today’s pre-market trading session. Gambling.com Group Limited (NASDAQ:GAMB) shares dipped 10.4% to $9.86 in pre-market trading after the company reported pricing of secondary offering of ordinary shares by selling shareholders. BeiGene, Ltd. (NASDAQ:BGNE) shares dropped 9% to $189.47 in pre-market trading. Beigene said updated analysis from Phase 2 Rosewood Trial of Brukinsa Plus Obinutuzumab showed clinically meaningful activity and was generally well-tolerated in pretreated relapsed or refractory follicular lymphoma patients. Editas Medicine, Inc. (NASDAQ:EDIT) shares fell 7.4% to $10.26 in pre-m
- INSIDERSEC Form 4 filed by Bank Of America Corp /De/4 - Crescera Capital Acquisition Corp. (0001851230) (Issuer)
- INSIDERSEC Form 3 filed by new insider Bank Of America Corp /De/3 - Crescera Capital Acquisition Corp. (0001851230) (Issuer)
- INSIDERSEC Form 4 filed by Wolverine Asset Management Llc4 - Crescera Capital Acquisition Corp. (0001851230) (Issuer)
- INSIDERSEC Form 3: New insider Wolverine Asset Management Llc claimed ownership of 20,161 units of Class A Ordinary Shares3 - Crescera Capital Acquisition Corp. (0001851230) (Issuer)
- SECSEC Form 10-Q filed by Crescera Capital Acquisition Corp10-Q - Crescera Capital Acquisition Corp. (0001851230) (Filer)
- SECSEC Form DEFA14A filed by Crescera Capital Acquisition CorpDEFA14A - Crescera Capital Acquisition Corp. (0001851230) (Filer)
- SECCrescera Capital Acquisition Corp filed SEC Form 8-K: Other Events, Financial Statements and Exhibits8-K - Crescera Capital Acquisition Corp. (0001851230) (Filer)
- SECSEC Form DEF 14A filed by Crescera Capital Acquisition CorpDEF 14A - Crescera Capital Acquisition Corp. (0001851230) (Filer)
- SECSEC Form 10-K filed by Crescera Capital Acquisition Corp10-K - Crescera Capital Acquisition Corp. (0001851230) (Filer)
- SECSEC Form PRE 14A filed by Crescera Capital Acquisition CorpPRE 14A - Crescera Capital Acquisition Corp. (0001851230) (Filer)
- SECSEC Form NT 10-K filed by Crescera Capital Acquisition CorpNT 10-K - Crescera Capital Acquisition Corp. (0001851230) (Filer)
- 13D/GSEC Form SC 13G/A filed by Crescera Capital Acquisition Corp (Amendment)SC 13G/A - Crescera Capital Acquisition Corp. (0001851230) (Subject)
CREC FAQ
7 questionsWhat does Crescera Capital Acquisition Corp do?
Crescera Capital Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar combination with one or more businesses in technology, healthcare, education services, consumer, and retail sectors in Latin America. The company was incorporated in 2021 and is based in Rio de Janeiro, Brazil.What is the latest news on CREC?
Quantisnow has not tracked any new filings, ratings or press releases for CREC in the last 30 days. The most recent wire item was published on February 14, 2024.Where does CREC stock trade?
Crescera Capital Acquisition Corp (CREC) is listed on NASDAQ.What sector and industry is CREC in?
Crescera Capital Acquisition Corp operates in the Finance sector, Blank Checks industry.When did Crescera Capital Acquisition Corp go public?
Crescera Capital Acquisition Corp (CREC) completed its IPO in 2022.What companies are similar to CREC?
Notable peers in the same industry include PRE (Prenetics Global Limited), OXSQ (Oxford Square Capital Corp.), INV (Innventure Inc.), ILLU (Illumination Acquisition Corp I), TACO (Berto Acquisition Corp.). Compare CREC side-by-side with any of them on Quantisnow.How can I track CREC on Quantisnow?
Quantisnow aggregates Crescera Capital Acquisition Corp's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow CREC to receive live email and push alerts on every new disclosure.